Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT04263051 |
Title | Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer (Optim-UCPVax) |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | Yes |
Sponsors | Centre Hospitalier Universitaire de Besancon |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | FRA |